ASSESSMENT OF VITAMIN D AND CALCIUM LEVELS IN WOMEN WITH PCOS: AN OBSERVATIONAL STUDY
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i12.46060Keywords:
Vitamin D, Polycystic ovarian syndrome, CalciumAbstract
Objectives: Polycystic ovarian syndrome (PCOS) is a prevalent endocrinal disorder in the women of reproductive age group. The present study aims to investigate the correlation between Vitamin D and calcium levels in PCOS subjects as well as to establish the correlation between body mass index, hyperandrogenism, and metabolic syndrome in various phenotypes of PCOS.
Methods: In the present prospective and observational study, a total of 80 patients diagnosed with PCOS were recruited. The recruited patients were divided in the following two groups - study group (60 women diagnosed with PCOS based on Rotterdam criteria); and control group (20 women without PCOS recruited from outpatient department and infertility clinics). Baseline characteristics, Vitamin D level, and serum calcium levels were measured in the two groups and then compared.
Results: The mean age of patients in both the groups was found to be comparable (study group: 26.45±5.95 years versus control group: 28.40±6.65 years; p=0.221). The difference of mean 25-Hydroxy Vitamin D3 level was found to be statistically highly significant (study group 14.71 [±9.12] ng/mL versus control group was 22.47 [±6.71] ng/mL; p=0.0008). The difference of mean serum calcium level was also found to be statistically highly significant (study group 9.14 [±0.50] mg/mL, and control group 9.74 [±0.45] mg/mL; p<0.0001).
Conclusion: Women with PCOS have a significantly lower serum 25-hydroxyvitamin D and calcium levels as compared to controls. There is need for routine Vitamin D3 and calcium screening in all patients of PCOS for better insight into its role in the syndrome. Screening and correction of Vitamin D3 and calcium deficiency may prevent PCOS and its manifestations.
Downloads
References
El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Poly cystic ovarian syndrome: An updated overview. Front Physiol 2016;7:124. doi: 10.3389/fphys.2016.00124, PMID 27092084
Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obste Gynecol 1935;29:181-91. doi: 10.1016/ S0002-9378(15)30642-6
Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech 2009;2:231-7. doi: 10.1242/dmm.001180, PMID 19407331
Mandrelle K, Kamath MS, Bondu DJ, Chandy A, Aleyamma T, George K. Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India. J Hum Reprod Sci 2012;5:26-31. doi: 10.4103/0974- 1208.97791, PMID 22870011
Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 2016;106:6-15. doi: 10.1016/j.fertnstert.2016.05.003, PMID 27233760
Brady C, Mousa SS, Mousa SA. Polycystic ovary syndrome and its impact on women’s quality of life: More than just an endocrine disorder. Drug Healthc Patient Saf 2009;1:9-15. doi: 10.2147/dhps.s4388, PMID 21701605
Palomba S, Santagni S, Falbo A, La Sala GB. Complications and challenges associated with polycystic ovary syndrome: Current perspectives. Int J Womens Health 2015;7:745-63. doi: 10.2147/IJWH. S70314, PMID 26261426
Ni CM, Huang WL, Jiang YM, Xu J, Duan R, Zhu YL, et al. Improving the accuracy and efficacy of diagnosing polycystic ovary syndrome by integrating metabolomics with clinical characteristics: Study protocol for a randomized controlled trial. Trials 2020;21:169. doi: 10.1186/ s13063-020-4060-6, PMID 32046752
Huang CC, Tien YJ, Chen MJ, Chen CH, Ho HN, Yang YS. Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: Association between endocrine characteristics and metabolic aberrations. Hum Reprod 2015;30:937-46. doi: 10.1093/ humrep/dev010, PMID 25662806
Kim JJ, Choi YM, Chae SJ, Hwang KR, Yoon SH, Kim MJ, et al. Vitamin D deficiency in women with polycystic ovary syndrome. Clin Exp Reprod Med 2014;41:80-5. doi: 10.5653/cerm.2014.41.2.80, PMID 25045632
Witchel SF, Oberfield SE, Peña AS. Polycystic ovary syndrome: Pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc 2019;3:1545-73. doi: 10.1210/js.2019- 00078, PMID 31384717
Firouzabadi RD, Aflatoonian A, Modarresi S, Sekhavat L, MohammadTaheri S. Therapeutic effects of calcium and Vitamin D supplementation in women with PCOS. Complement Ther Clin Pract 2012;18:85-8. doi: 10.1016/j.ctcp.2012.01.005, PMID 22500844
Gowri C, Ramana GV. Impact of socio-economic status on poly cystic ovarian syndrome (A study at Anantapur district, Andra Pradesh). East Afr Scholars J Med Sci 2020;3:21-5
Shojaeian Z, Sadeghi R, Roudsari RL. Calcium and Vitamin D supplementation effects on metabolic factors, menstrual cycles and follicular responses in women with polycystic ovary syndrome: A systematic review and meta-analysis. Caspian J Intern Med 2019;10:359-69. doi: 10.22088/cjim.10.4.359, PMID 31814932
Thys-Jacobs S, Donovan D, Papadopoulos A, Sarrel P, Bilezikian JP. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids. 1999;64:430-5. doi: 10.1016/s0039-128x(99)00012-4. PMID: 10433180.
Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG, et al. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 2009;280:559-63. doi: 10.1007/s00404-009-0958-7, PMID 19214546
Slyper AH, Kashmer L, Huang WM, Re’em Y. Acanthosis nigricans, Vitamin D, and insulin resistance in obese children and adolescents. J Pediatr Endocrinol Metab 2014;27:1107-11. doi: 10.1515/jpem-2013- 0465, PMID 25010776
Mazloomi S, Sharifi F, Hajihosseini R, Kalantari S, Mazloomzadeh S. Association between hypoadiponectinemia and low serum concentrations of calcium and Vitamin D in women with polycystic ovary syndrome. ISRN Endocrinol 2012;2012:949427. doi: 10.5402/2012/949427, PMID 22363895
Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR, et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol 2009;161:575-82. doi: 10.1530/EJE-09-0432, PMID 19628650
Subashree I, Valvekar UR, Prasad G. Study of serum calcium and Vitamin D levels with hormonal profile along with biochemical profile in women with polycystic ovary syndrome. Int J Reprod Contracept Obstet Gynecol 2017;6:4075-80. doi: 10.18203/2320-1770. ijrcog20174065
Mazloomi S, Sharifi F, Hajihosseini R, Kalantari S, Mazloomzadeh S. Association between hypoadiponectinemia and low serum concentrations of calcium and Vitamin D in women with polycystic ovary syndrome. ISRN Endocrinol 2012;2012:949427. doi: 10.5402/2012/949427, PMID 22363895
Lagunova Z, Porojnicu AC, Lindberg F, Hexeberg S, Moan J. The dependency of Vitamin D status on body mass index, gender, age and season. Anticancer Res 2009;29:3713-20. doi: 10.14341/2071-8713- 4886, PMID 19667169
Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG. Role of Vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril 2009;92:1053-8. doi: 10.1016/j.fertnstert.2008.07.1757, PMID 18930208
Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc 2011;86:50-60. doi: 10.4065/mcp.2010.0567, PMID 21193656
Nandi A, Sinha N, Ong E, Sonmez H, Poretsky L. Is there a role for Vitamin D in human reproduction? Horm Mol Biol Clin Investig 2016;25:15-28. doi: 10.1515/hmbci-2015-0051, PMID 26943610
Toosi P, Azizan Z, Yavari H, Fakhim TH, Amini SH, Enamzade R. Serum 25-hydroxy Vitamin D levels in patients with acne vulgaris and its association with disease severity. Clin Cases Miner Bone Metab 2015;12:238-42. doi: 10.11138/ccmbm/2015.12.3.238
Published
How to Cite
Issue
Section
Copyright (c) 2022 Dr Saru, DrParneet Kaur, Dr Rama Garg, Dr Maninder Kaur, Sangeeta Aggarwal
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
